Proteomics International Laboratories |
High $0.88 |
Low $0.86 |
Trades 19 |
Turnover $55,369 |
Volume 64,140 |
| 30 June 2023 at 3:08pm | ||||
|
Market Cap (13-Nov) $16,206,565 (840th) |
Close (30-Jun) $0.86 |
Volume (30-Jun) 64,140 |
Shortsold (6-Nov) 92,277 (0.06%) (494th) |
|
52w High $0.86 |
52w Low $0.090 |
P/E - |
EPS -0.05 |
Trading Halt
PIQ released this announcement to the ASX on 21 October 2020, 9:24. The announcement is marked as price sensitive, and is 2 page(s) in length and 406.68kb in size.
You can view all announcements from PIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, PIQ was 0.095% short sold according to ASIC data. It was ranked the 411th most shorted stock on the ASX. It remains ranked 494th as of the latest reported data (06 November 2026).
| Other Recent Announcements from PIQ | |
|---|---|
| Sonic Healthcare USA signs licence for PromarkerD in the US | 10 May 2023, 11:41 |
| Trading Halt | 8 May 2023, 9:15 |
| World Endometriosis Congress - New diagnostic test showcased | 5 May 2023, 8:15 |
| Canagliflozin lowers PromarkerD DKD risk prediction scores | 3 May 2023, 8:15 |
| Notification of cessation of securities - PIQ | 1 May 2023, 17:03 |
| Trading Halt | 21 October 2020, 9:24 |
| First distribution agreement for PromarkerD immunoassay | 16 October 2020, 8:17 |
If you were already registered, log in here.